P3 Health Partners Inc.
P3 Health Partners Inc. (PIIIW) Stock Competitors & Peer Comparison
See (PIIIW) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Care Facilities Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| PIIIW | $0.01 | -1.94% | 33K | -0.01 | -$1.34 | N/A |
| HCA | $340.54 | +1.86% | 81.9B | 14.30 | $23.80 | +0.83% |
| FMS | $25.83 | -2.27% | 15.2B | 20.83 | $1.24 | +2.99% |
| THC | $156.52 | +2.29% | 14.5B | 9.83 | $15.91 | N/A |
| SOLV | $73.77 | -1.31% | 12.8B | 34.00 | $2.17 | N/A |
| DVA | $145.31 | +0.10% | 11B | 14.43 | $10.07 | N/A |
| EHC | $107.17 | -0.46% | 10.8B | 22.05 | $4.86 | +0.63% |
| UHS | $154.95 | -0.42% | 10B | 8.71 | $17.80 | +0.52% |
| OSH | $39.00 | +0.08% | 9.5B | -17.65 | -$2.21 | N/A |
| ENSG | $147.78 | -1.52% | 8.5B | 26.77 | $5.52 | +0.16% |
Stock Comparison
PIIIW vs HCA Comparison July 2025
PIIIW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 33K. In comparison, HCA has a market cap of 81.9B. Regarding current trading prices, PIIIW is priced at $0.01, while HCA trades at $340.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of -0.01, whereas HCA's P/E ratio is 14.30. In terms of profitability, PIIIW's ROE is -1.29%, compared to HCA's ROE of -2.11%. Regarding short-term risk, PIIIW is more volatile compared to HCA. This indicates potentially higher risk in terms of short-term price fluctuations for PIIIW.Check HCA's competition here
PIIIW vs FMS Comparison July 2025
PIIIW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 33K. In comparison, FMS has a market cap of 15.2B. Regarding current trading prices, PIIIW is priced at $0.01, while FMS trades at $25.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of -0.01, whereas FMS's P/E ratio is 20.83. In terms of profitability, PIIIW's ROE is -1.29%, compared to FMS's ROE of +0.04%. Regarding short-term risk, PIIIW is more volatile compared to FMS. This indicates potentially higher risk in terms of short-term price fluctuations for PIIIW.Check FMS's competition here
PIIIW vs THC Comparison July 2025
PIIIW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 33K. In comparison, THC has a market cap of 14.5B. Regarding current trading prices, PIIIW is priced at $0.01, while THC trades at $156.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of -0.01, whereas THC's P/E ratio is 9.83. In terms of profitability, PIIIW's ROE is -1.29%, compared to THC's ROE of +0.37%. Regarding short-term risk, PIIIW is more volatile compared to THC. This indicates potentially higher risk in terms of short-term price fluctuations for PIIIW.Check THC's competition here
PIIIW vs SOLV Comparison July 2025
PIIIW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 33K. In comparison, SOLV has a market cap of 12.8B. Regarding current trading prices, PIIIW is priced at $0.01, while SOLV trades at $73.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of -0.01, whereas SOLV's P/E ratio is 34.00. In terms of profitability, PIIIW's ROE is -1.29%, compared to SOLV's ROE of +0.12%. Regarding short-term risk, PIIIW is more volatile compared to SOLV. This indicates potentially higher risk in terms of short-term price fluctuations for PIIIW.Check SOLV's competition here
PIIIW vs DVA Comparison July 2025
PIIIW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 33K. In comparison, DVA has a market cap of 11B. Regarding current trading prices, PIIIW is priced at $0.01, while DVA trades at $145.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of -0.01, whereas DVA's P/E ratio is 14.43. In terms of profitability, PIIIW's ROE is -1.29%, compared to DVA's ROE of +3.94%. Regarding short-term risk, PIIIW is more volatile compared to DVA. This indicates potentially higher risk in terms of short-term price fluctuations for PIIIW.Check DVA's competition here
PIIIW vs EHC Comparison July 2025
PIIIW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 33K. In comparison, EHC has a market cap of 10.8B. Regarding current trading prices, PIIIW is priced at $0.01, while EHC trades at $107.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of -0.01, whereas EHC's P/E ratio is 22.05. In terms of profitability, PIIIW's ROE is -1.29%, compared to EHC's ROE of +0.25%. Regarding short-term risk, PIIIW is more volatile compared to EHC. This indicates potentially higher risk in terms of short-term price fluctuations for PIIIW.Check EHC's competition here
PIIIW vs UHS Comparison July 2025
PIIIW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 33K. In comparison, UHS has a market cap of 10B. Regarding current trading prices, PIIIW is priced at $0.01, while UHS trades at $154.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of -0.01, whereas UHS's P/E ratio is 8.71. In terms of profitability, PIIIW's ROE is -1.29%, compared to UHS's ROE of +0.18%. Regarding short-term risk, PIIIW is more volatile compared to UHS. This indicates potentially higher risk in terms of short-term price fluctuations for PIIIW.Check UHS's competition here
PIIIW vs OSH Comparison July 2025
PIIIW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 33K. In comparison, OSH has a market cap of 9.5B. Regarding current trading prices, PIIIW is priced at $0.01, while OSH trades at $39.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of -0.01, whereas OSH's P/E ratio is -17.65. In terms of profitability, PIIIW's ROE is -1.29%, compared to OSH's ROE of +4.64%. Regarding short-term risk, PIIIW is more volatile compared to OSH. This indicates potentially higher risk in terms of short-term price fluctuations for PIIIW.Check OSH's competition here
PIIIW vs ENSG Comparison July 2025
PIIIW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 33K. In comparison, ENSG has a market cap of 8.5B. Regarding current trading prices, PIIIW is priced at $0.01, while ENSG trades at $147.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of -0.01, whereas ENSG's P/E ratio is 26.77. In terms of profitability, PIIIW's ROE is -1.29%, compared to ENSG's ROE of +0.17%. Regarding short-term risk, PIIIW is more volatile compared to ENSG. This indicates potentially higher risk in terms of short-term price fluctuations for PIIIW.Check ENSG's competition here
PIIIW vs CHE Comparison July 2025
PIIIW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 33K. In comparison, CHE has a market cap of 6.8B. Regarding current trading prices, PIIIW is priced at $0.01, while CHE trades at $466.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of -0.01, whereas CHE's P/E ratio is 22.74. In terms of profitability, PIIIW's ROE is -1.29%, compared to CHE's ROE of +0.26%. Regarding short-term risk, PIIIW is more volatile compared to CHE. This indicates potentially higher risk in terms of short-term price fluctuations for PIIIW.Check CHE's competition here
PIIIW vs LHCG Comparison July 2025
PIIIW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 33K. In comparison, LHCG has a market cap of 5.3B. Regarding current trading prices, PIIIW is priced at $0.01, while LHCG trades at $169.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of -0.01, whereas LHCG's P/E ratio is 82.83. In terms of profitability, PIIIW's ROE is -1.29%, compared to LHCG's ROE of +0.04%. Regarding short-term risk, PIIIW is more volatile compared to LHCG. This indicates potentially higher risk in terms of short-term price fluctuations for PIIIW.Check LHCG's competition here
PIIIW vs OPCH Comparison July 2025
PIIIW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 33K. In comparison, OPCH has a market cap of 4.9B. Regarding current trading prices, PIIIW is priced at $0.01, while OPCH trades at $29.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of -0.01, whereas OPCH's P/E ratio is 23.82. In terms of profitability, PIIIW's ROE is -1.29%, compared to OPCH's ROE of +0.15%. Regarding short-term risk, PIIIW is more volatile compared to OPCH. This indicates potentially higher risk in terms of short-term price fluctuations for PIIIW.Check OPCH's competition here
PIIIW vs AMED Comparison July 2025
PIIIW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 33K. In comparison, AMED has a market cap of 3.2B. Regarding current trading prices, PIIIW is priced at $0.01, while AMED trades at $96.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of -0.01, whereas AMED's P/E ratio is 35.76. In terms of profitability, PIIIW's ROE is -1.29%, compared to AMED's ROE of +0.10%. Regarding short-term risk, PIIIW is more volatile compared to AMED. This indicates potentially higher risk in terms of short-term price fluctuations for PIIIW.Check AMED's competition here
PIIIW vs SGRY Comparison July 2025
PIIIW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 33K. In comparison, SGRY has a market cap of 2.9B. Regarding current trading prices, PIIIW is priced at $0.01, while SGRY trades at $22.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of -0.01, whereas SGRY's P/E ratio is -14.67. In terms of profitability, PIIIW's ROE is -1.29%, compared to SGRY's ROE of -0.10%. Regarding short-term risk, PIIIW is more volatile compared to SGRY. This indicates potentially higher risk in terms of short-term price fluctuations for PIIIW.Check SGRY's competition here
PIIIW vs ACHC Comparison July 2025
PIIIW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 33K. In comparison, ACHC has a market cap of 2.1B. Regarding current trading prices, PIIIW is priced at $0.01, while ACHC trades at $22.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of -0.01, whereas ACHC's P/E ratio is 11.12. In terms of profitability, PIIIW's ROE is -1.29%, compared to ACHC's ROE of +0.06%. Regarding short-term risk, PIIIW is more volatile compared to ACHC. This indicates potentially higher risk in terms of short-term price fluctuations for PIIIW.Check ACHC's competition here
PIIIW vs ADUS Comparison July 2025
PIIIW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 33K. In comparison, ADUS has a market cap of 2B. Regarding current trading prices, PIIIW is priced at $0.01, while ADUS trades at $109.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of -0.01, whereas ADUS's P/E ratio is 24.69. In terms of profitability, PIIIW's ROE is -1.29%, compared to ADUS's ROE of +0.08%. Regarding short-term risk, PIIIW is more volatile compared to ADUS. This indicates potentially higher risk in terms of short-term price fluctuations for PIIIW.Check ADUS's competition here
PIIIW vs AMEH Comparison July 2025
PIIIW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 33K. In comparison, AMEH has a market cap of 1.8B. Regarding current trading prices, PIIIW is priced at $0.01, while AMEH trades at $40.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of -0.01, whereas AMEH's P/E ratio is 39.25. In terms of profitability, PIIIW's ROE is -1.29%, compared to AMEH's ROE of +0.07%. Regarding short-term risk, PIIIW is more volatile compared to AMEH. This indicates potentially higher risk in terms of short-term price fluctuations for PIIIW.Check AMEH's competition here
PIIIW vs SEM Comparison July 2025
PIIIW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 33K. In comparison, SEM has a market cap of 1.8B. Regarding current trading prices, PIIIW is priced at $0.01, while SEM trades at $14.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of -0.01, whereas SEM's P/E ratio is 22.82. In terms of profitability, PIIIW's ROE is -1.29%, compared to SEM's ROE of +0.10%. Regarding short-term risk, PIIIW is more volatile compared to SEM. This indicates potentially higher risk in terms of short-term price fluctuations for PIIIW.Check SEM's competition here
PIIIW vs BKD Comparison July 2025
PIIIW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 33K. In comparison, BKD has a market cap of 1.8B. Regarding current trading prices, PIIIW is priced at $0.01, while BKD trades at $7.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of -0.01, whereas BKD's P/E ratio is -7.20. In terms of profitability, PIIIW's ROE is -1.29%, compared to BKD's ROE of -0.96%. Regarding short-term risk, PIIIW is more volatile compared to BKD. This indicates potentially higher risk in terms of short-term price fluctuations for PIIIW.Check BKD's competition here
PIIIW vs LFST Comparison July 2025
PIIIW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 33K. In comparison, LFST has a market cap of 1.6B. Regarding current trading prices, PIIIW is priced at $0.01, while LFST trades at $4.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of -0.01, whereas LFST's P/E ratio is -46.33. In terms of profitability, PIIIW's ROE is -1.29%, compared to LFST's ROE of -0.02%. Regarding short-term risk, PIIIW is more volatile compared to LFST. This indicates potentially higher risk in terms of short-term price fluctuations for PIIIW.Check LFST's competition here
PIIIW vs ARDT Comparison July 2025
PIIIW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 33K. In comparison, ARDT has a market cap of 1.5B. Regarding current trading prices, PIIIW is priced at $0.01, while ARDT trades at $10.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of -0.01, whereas ARDT's P/E ratio is 6.35. In terms of profitability, PIIIW's ROE is -1.29%, compared to ARDT's ROE of +0.24%. Regarding short-term risk, PIIIW is more volatile compared to ARDT. This indicates potentially higher risk in terms of short-term price fluctuations for PIIIW.Check ARDT's competition here
PIIIW vs NHC Comparison July 2025
PIIIW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 33K. In comparison, NHC has a market cap of 1.5B. Regarding current trading prices, PIIIW is priced at $0.01, while NHC trades at $95.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of -0.01, whereas NHC's P/E ratio is 13.91. In terms of profitability, PIIIW's ROE is -1.29%, compared to NHC's ROE of +0.11%. Regarding short-term risk, PIIIW is more volatile compared to NHC. This indicates potentially higher risk in terms of short-term price fluctuations for PIIIW.Check NHC's competition here
PIIIW vs BKDT Comparison July 2025
PIIIW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 33K. In comparison, BKDT has a market cap of 1.2B. Regarding current trading prices, PIIIW is priced at $0.01, while BKDT trades at $77.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of -0.01, whereas BKDT's P/E ratio is N/A. In terms of profitability, PIIIW's ROE is -1.29%, compared to BKDT's ROE of -0.96%. Regarding short-term risk, PIIIW is more volatile compared to BKDT. This indicates potentially higher risk in terms of short-term price fluctuations for PIIIW.Check BKDT's competition here
PIIIW vs ASTH Comparison July 2025
PIIIW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 33K. In comparison, ASTH has a market cap of 1.2B. Regarding current trading prices, PIIIW is priced at $0.01, while ASTH trades at $23.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of -0.01, whereas ASTH's P/E ratio is 32.41. In terms of profitability, PIIIW's ROE is -1.29%, compared to ASTH's ROE of +0.07%. Regarding short-term risk, PIIIW is more volatile compared to ASTH. This indicates potentially higher risk in terms of short-term price fluctuations for PIIIW.Check ASTH's competition here
PIIIW vs USPH Comparison July 2025
PIIIW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 33K. In comparison, USPH has a market cap of 1.1B. Regarding current trading prices, PIIIW is priced at $0.01, while USPH trades at $75.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of -0.01, whereas USPH's P/E ratio is 34.59. In terms of profitability, PIIIW's ROE is -1.29%, compared to USPH's ROE of +0.06%. Regarding short-term risk, PIIIW is more volatile compared to USPH. This indicates potentially higher risk in terms of short-term price fluctuations for PIIIW.Check USPH's competition here
PIIIW vs MD Comparison July 2025
PIIIW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 33K. In comparison, MD has a market cap of 1.1B. Regarding current trading prices, PIIIW is priced at $0.01, while MD trades at $12.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of -0.01, whereas MD's P/E ratio is -12.66. In terms of profitability, PIIIW's ROE is -1.29%, compared to MD's ROE of -0.11%. Regarding short-term risk, PIIIW is more volatile compared to MD. This indicates potentially higher risk in terms of short-term price fluctuations for PIIIW.Check MD's competition here
PIIIW vs HCSG Comparison July 2025
PIIIW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 33K. In comparison, HCSG has a market cap of 966.2M. Regarding current trading prices, PIIIW is priced at $0.01, while HCSG trades at $13.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of -0.01, whereas HCSG's P/E ratio is 94.64. In terms of profitability, PIIIW's ROE is -1.29%, compared to HCSG's ROE of +0.02%. Regarding short-term risk, PIIIW is more volatile compared to HCSG. This indicates potentially higher risk in terms of short-term price fluctuations for PIIIW.Check HCSG's competition here
PIIIW vs AGL Comparison July 2025
PIIIW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 33K. In comparison, AGL has a market cap of 825.8M. Regarding current trading prices, PIIIW is priced at $0.01, while AGL trades at $1.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of -0.01, whereas AGL's P/E ratio is -3.22. In terms of profitability, PIIIW's ROE is -1.29%, compared to AGL's ROE of -0.44%. Regarding short-term risk, PIIIW is more volatile compared to AGL. This indicates potentially higher risk in terms of short-term price fluctuations for PIIIW.Check AGL's competition here
PIIIW vs PNTG Comparison July 2025
PIIIW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 33K. In comparison, PNTG has a market cap of 800.4M. Regarding current trading prices, PIIIW is priced at $0.01, while PNTG trades at $23.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of -0.01, whereas PNTG's P/E ratio is 30.55. In terms of profitability, PIIIW's ROE is -1.29%, compared to PNTG's ROE of +0.11%. Regarding short-term risk, PIIIW is more volatile compared to PNTG. This indicates potentially higher risk in terms of short-term price fluctuations for PIIIW.Check PNTG's competition here
PIIIW vs AVAH Comparison July 2025
PIIIW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 33K. In comparison, AVAH has a market cap of 770.6M. Regarding current trading prices, PIIIW is priced at $0.01, while AVAH trades at $3.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of -0.01, whereas AVAH's P/E ratio is 131.67. In terms of profitability, PIIIW's ROE is -1.29%, compared to AVAH's ROE of -0.12%. Regarding short-term risk, PIIIW is more volatile compared to AVAH. This indicates potentially higher risk in terms of short-term price fluctuations for PIIIW.Check AVAH's competition here
PIIIW vs AMN Comparison July 2025
PIIIW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 33K. In comparison, AMN has a market cap of 753.1M. Regarding current trading prices, PIIIW is priced at $0.01, while AMN trades at $19.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of -0.01, whereas AMN's P/E ratio is -4.54. In terms of profitability, PIIIW's ROE is -1.29%, compared to AMN's ROE of -0.21%. Regarding short-term risk, PIIIW is more volatile compared to AMN. This indicates potentially higher risk in terms of short-term price fluctuations for PIIIW.Check AMN's competition here
PIIIW vs INNV Comparison July 2025
PIIIW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 33K. In comparison, INNV has a market cap of 506.3M. Regarding current trading prices, PIIIW is priced at $0.01, while INNV trades at $3.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of -0.01, whereas INNV's P/E ratio is -15.62. In terms of profitability, PIIIW's ROE is -1.29%, compared to INNV's ROE of -0.12%. Regarding short-term risk, PIIIW is more volatile compared to INNV. This indicates potentially higher risk in terms of short-term price fluctuations for PIIIW.Check INNV's competition here
PIIIW vs SNDA Comparison July 2025
PIIIW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 33K. In comparison, SNDA has a market cap of 466.4M. Regarding current trading prices, PIIIW is priced at $0.01, while SNDA trades at $24.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of -0.01, whereas SNDA's P/E ratio is -6.81. In terms of profitability, PIIIW's ROE is -1.29%, compared to SNDA's ROE of -0.53%. Regarding short-term risk, PIIIW is more volatile compared to SNDA. This indicates potentially higher risk in terms of short-term price fluctuations for PIIIW.Check SNDA's competition here
PIIIW vs AUNA Comparison July 2025
PIIIW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 33K. In comparison, AUNA has a market cap of 457.4M. Regarding current trading prices, PIIIW is priced at $0.01, while AUNA trades at $6.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of -0.01, whereas AUNA's P/E ratio is 9.36. In terms of profitability, PIIIW's ROE is -1.29%, compared to AUNA's ROE of +0.11%. Regarding short-term risk, PIIIW is more volatile compared to AUNA. This indicates potentially higher risk in terms of short-term price fluctuations for PIIIW.Check AUNA's competition here
PIIIW vs CCRN Comparison July 2025
PIIIW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 33K. In comparison, CCRN has a market cap of 452.7M. Regarding current trading prices, PIIIW is priced at $0.01, while CCRN trades at $13.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of -0.01, whereas CCRN's P/E ratio is -25.57. In terms of profitability, PIIIW's ROE is -1.29%, compared to CCRN's ROE of -0.04%. Regarding short-term risk, PIIIW is more volatile compared to CCRN. This indicates potentially higher risk in terms of short-term price fluctuations for PIIIW.Check CCRN's competition here
PIIIW vs TALKW Comparison July 2025
PIIIW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 33K. In comparison, TALKW has a market cap of 430.2M. Regarding current trading prices, PIIIW is priced at $0.01, while TALKW trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of -0.01, whereas TALKW's P/E ratio is N/A. In terms of profitability, PIIIW's ROE is -1.29%, compared to TALKW's ROE of -0.04%. Regarding short-term risk, PIIIW is more volatile compared to TALKW. This indicates potentially higher risk in terms of short-term price fluctuations for PIIIW.Check TALKW's competition here
PIIIW vs TALK Comparison July 2025
PIIIW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 33K. In comparison, TALK has a market cap of 428.3M. Regarding current trading prices, PIIIW is priced at $0.01, while TALK trades at $2.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of -0.01, whereas TALK's P/E ratio is 128.00. In terms of profitability, PIIIW's ROE is -1.29%, compared to TALK's ROE of -0.04%. Regarding short-term risk, PIIIW is more volatile compared to TALK. This indicates potentially higher risk in terms of short-term price fluctuations for PIIIW.Check TALK's competition here
PIIIW vs CMPS Comparison July 2025
PIIIW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 33K. In comparison, CMPS has a market cap of 406.1M. Regarding current trading prices, PIIIW is priced at $0.01, while CMPS trades at $4.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of -0.01, whereas CMPS's P/E ratio is -2.18. In terms of profitability, PIIIW's ROE is -1.29%, compared to CMPS's ROE of -0.72%. Regarding short-term risk, PIIIW is more volatile compared to CMPS. This indicates potentially higher risk in terms of short-term price fluctuations for PIIIW.Check CMPS's competition here
PIIIW vs AIRS Comparison July 2025
PIIIW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 33K. In comparison, AIRS has a market cap of 395.4M. Regarding current trading prices, PIIIW is priced at $0.01, while AIRS trades at $6.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of -0.01, whereas AIRS's P/E ratio is -21.84. In terms of profitability, PIIIW's ROE is -1.29%, compared to AIRS's ROE of -0.21%. Regarding short-term risk, PIIIW is more volatile compared to AIRS. This indicates potentially higher risk in terms of short-term price fluctuations for PIIIW.Check AIRS's competition here
PIIIW vs CYH Comparison July 2025
PIIIW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 33K. In comparison, CYH has a market cap of 362.2M. Regarding current trading prices, PIIIW is priced at $0.01, while CYH trades at $2.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of -0.01, whereas CYH's P/E ratio is -1.76. In terms of profitability, PIIIW's ROE is -1.29%, compared to CYH's ROE of +0.11%. Regarding short-term risk, PIIIW is more volatile compared to CYH. This indicates potentially higher risk in terms of short-term price fluctuations for PIIIW.Check CYH's competition here
PIIIW vs TOIIW Comparison July 2025
PIIIW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 33K. In comparison, TOIIW has a market cap of 357.6M. Regarding current trading prices, PIIIW is priced at $0.01, while TOIIW trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of -0.01, whereas TOIIW's P/E ratio is N/A. In terms of profitability, PIIIW's ROE is -1.29%, compared to TOIIW's ROE of -4.83%. Regarding short-term risk, PIIIW is more volatile compared to TOIIW. This indicates potentially higher risk in terms of short-term price fluctuations for PIIIW.Check TOIIW's competition here
PIIIW vs TOI Comparison July 2025
PIIIW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 33K. In comparison, TOI has a market cap of 346.5M. Regarding current trading prices, PIIIW is priced at $0.01, while TOI trades at $3.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of -0.01, whereas TOI's P/E ratio is -5.39. In terms of profitability, PIIIW's ROE is -1.29%, compared to TOI's ROE of -4.83%. Regarding short-term risk, PIIIW is more volatile compared to TOI. This indicates potentially higher risk in terms of short-term price fluctuations for PIIIW.Check TOI's competition here
PIIIW vs EHAB Comparison July 2025
PIIIW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 33K. In comparison, EHAB has a market cap of 344.1M. Regarding current trading prices, PIIIW is priced at $0.01, while EHAB trades at $6.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of -0.01, whereas EHAB's P/E ratio is -2.45. In terms of profitability, PIIIW's ROE is -1.29%, compared to EHAB's ROE of -0.31%. Regarding short-term risk, PIIIW is more volatile compared to EHAB. This indicates potentially higher risk in terms of short-term price fluctuations for PIIIW.Check EHAB's competition here
PIIIW vs AONC Comparison July 2025
PIIIW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 33K. In comparison, AONC has a market cap of 299M. Regarding current trading prices, PIIIW is priced at $0.01, while AONC trades at $10.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of -0.01, whereas AONC's P/E ratio is -11.52. In terms of profitability, PIIIW's ROE is -1.29%, compared to AONC's ROE of +0.25%. Regarding short-term risk, PIIIW is more volatile compared to AONC. This indicates potentially higher risk in terms of short-term price fluctuations for PIIIW.Check AONC's competition here
PIIIW vs CSU Comparison July 2025
PIIIW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 33K. In comparison, CSU has a market cap of 223.7M. Regarding current trading prices, PIIIW is priced at $0.01, while CSU trades at $33.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of -0.01, whereas CSU's P/E ratio is 0.67. In terms of profitability, PIIIW's ROE is -1.29%, compared to CSU's ROE of +2.23%. Regarding short-term risk, PIIIW is more volatile compared to CSU. This indicates potentially higher risk in terms of short-term price fluctuations for PIIIW.Check CSU's competition here
PIIIW vs JYNT Comparison July 2025
PIIIW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 33K. In comparison, JYNT has a market cap of 174.1M. Regarding current trading prices, PIIIW is priced at $0.01, while JYNT trades at $11.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of -0.01, whereas JYNT's P/E ratio is -113.80. In terms of profitability, PIIIW's ROE is -1.29%, compared to JYNT's ROE of -0.43%. Regarding short-term risk, PIIIW is more volatile compared to JYNT. This indicates potentially higher risk in terms of short-term price fluctuations for PIIIW.Check JYNT's competition here
PIIIW vs BTMD Comparison July 2025
PIIIW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 33K. In comparison, BTMD has a market cap of 167.3M. Regarding current trading prices, PIIIW is priced at $0.01, while BTMD trades at $4.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of -0.01, whereas BTMD's P/E ratio is 7.53. In terms of profitability, PIIIW's ROE is -1.29%, compared to BTMD's ROE of -0.19%. Regarding short-term risk, PIIIW is more volatile compared to BTMD. This indicates potentially higher risk in terms of short-term price fluctuations for PIIIW.Check BTMD's competition here
PIIIW vs DCGO Comparison July 2025
PIIIW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 33K. In comparison, DCGO has a market cap of 147.7M. Regarding current trading prices, PIIIW is priced at $0.01, while DCGO trades at $1.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of -0.01, whereas DCGO's P/E ratio is -149.00. In terms of profitability, PIIIW's ROE is -1.29%, compared to DCGO's ROE of -0.00%. Regarding short-term risk, PIIIW is more volatile compared to DCGO. This indicates potentially higher risk in terms of short-term price fluctuations for PIIIW.Check DCGO's competition here
PIIIW vs FVE Comparison July 2025
PIIIW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 33K. In comparison, FVE has a market cap of 98.4M. Regarding current trading prices, PIIIW is priced at $0.01, while FVE trades at $2.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of -0.01, whereas FVE's P/E ratio is -5.64. In terms of profitability, PIIIW's ROE is -1.29%, compared to FVE's ROE of -0.15%. Regarding short-term risk, PIIIW is more volatile compared to FVE. This indicates potentially higher risk in terms of short-term price fluctuations for PIIIW.Check FVE's competition here
PIIIW vs KDLYW Comparison July 2025
PIIIW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 33K. In comparison, KDLYW has a market cap of 96.5M. Regarding current trading prices, PIIIW is priced at $0.01, while KDLYW trades at $18.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of -0.01, whereas KDLYW's P/E ratio is N/A. In terms of profitability, PIIIW's ROE is -1.29%, compared to KDLYW's ROE of -1.46%. Regarding short-term risk, PIIIW is less volatile compared to KDLYW. This indicates potentially lower risk in terms of short-term price fluctuations for PIIIW.Check KDLYW's competition here
PIIIW vs MODV Comparison July 2025
PIIIW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 33K. In comparison, MODV has a market cap of 44.2M. Regarding current trading prices, PIIIW is priced at $0.01, while MODV trades at $3.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of -0.01, whereas MODV's P/E ratio is -0.19. In terms of profitability, PIIIW's ROE is -1.29%, compared to MODV's ROE of +6.87%. Regarding short-term risk, PIIIW is more volatile compared to MODV. This indicates potentially higher risk in terms of short-term price fluctuations for PIIIW.Check MODV's competition here
PIIIW vs ALR Comparison July 2025
PIIIW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 33K. In comparison, ALR has a market cap of 44.2M. Regarding current trading prices, PIIIW is priced at $0.01, while ALR trades at $1.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of -0.01, whereas ALR's P/E ratio is -1.11. In terms of profitability, PIIIW's ROE is -1.29%, compared to ALR's ROE of -0.15%. Regarding short-term risk, PIIIW is more volatile compared to ALR. This indicates potentially higher risk in terms of short-term price fluctuations for PIIIW.Check ALR's competition here
PIIIW vs CCEL Comparison July 2025
PIIIW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 33K. In comparison, CCEL has a market cap of 39.6M. Regarding current trading prices, PIIIW is priced at $0.01, while CCEL trades at $4.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of -0.01, whereas CCEL's P/E ratio is -246.00. In terms of profitability, PIIIW's ROE is -1.29%, compared to CCEL's ROE of +0.01%. Regarding short-term risk, PIIIW is more volatile compared to CCEL. This indicates potentially higher risk in terms of short-term price fluctuations for PIIIW.Check CCEL's competition here
PIIIW vs IMAC Comparison July 2025
PIIIW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 33K. In comparison, IMAC has a market cap of 33.1M. Regarding current trading prices, PIIIW is priced at $0.01, while IMAC trades at $1.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of -0.01, whereas IMAC's P/E ratio is -2.27. In terms of profitability, PIIIW's ROE is -1.29%, compared to IMAC's ROE of -0.78%. Regarding short-term risk, PIIIW is more volatile compared to IMAC. This indicates potentially higher risk in terms of short-term price fluctuations for PIIIW.Check IMAC's competition here
PIIIW vs PIII Comparison July 2025
PIIIW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 33K. In comparison, PIII has a market cap of 22.9M. Regarding current trading prices, PIIIW is priced at $0.01, while PIII trades at $7.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of -0.01, whereas PIII's P/E ratio is -0.13. In terms of profitability, PIIIW's ROE is -1.29%, compared to PIII's ROE of -1.29%. Regarding short-term risk, PIIIW is more volatile compared to PIII. This indicates potentially higher risk in terms of short-term price fluctuations for PIIIW.Check PIII's competition here
PIIIW vs AMS Comparison July 2025
PIIIW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 33K. In comparison, AMS has a market cap of 16.6M. Regarding current trading prices, PIIIW is priced at $0.01, while AMS trades at $2.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of -0.01, whereas AMS's P/E ratio is 12.29. In terms of profitability, PIIIW's ROE is -1.29%, compared to AMS's ROE of +0.06%. Regarding short-term risk, PIIIW is more volatile compared to AMS. This indicates potentially higher risk in terms of short-term price fluctuations for PIIIW.Check AMS's competition here
PIIIW vs AIH Comparison July 2025
PIIIW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 33K. In comparison, AIH has a market cap of 15.9M. Regarding current trading prices, PIIIW is priced at $0.01, while AIH trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of -0.01, whereas AIH's P/E ratio is -2.78. In terms of profitability, PIIIW's ROE is -1.29%, compared to AIH's ROE of +1.16%. Regarding short-term risk, PIIIW is less volatile compared to AIH. This indicates potentially lower risk in terms of short-term price fluctuations for PIIIW.Check AIH's competition here
PIIIW vs CANO Comparison July 2025
PIIIW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 33K. In comparison, CANO has a market cap of 12.4M. Regarding current trading prices, PIIIW is priced at $0.01, while CANO trades at $2.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of -0.01, whereas CANO's P/E ratio is -0.01. In terms of profitability, PIIIW's ROE is -1.29%, compared to CANO's ROE of -1.49%. Regarding short-term risk, PIIIW is more volatile compared to CANO. This indicates potentially higher risk in terms of short-term price fluctuations for PIIIW.Check CANO's competition here
PIIIW vs FTRP Comparison July 2025
PIIIW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 33K. In comparison, FTRP has a market cap of 9.8M. Regarding current trading prices, PIIIW is priced at $0.01, while FTRP trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of -0.01, whereas FTRP's P/E ratio is -1.22. In terms of profitability, PIIIW's ROE is -1.29%, compared to FTRP's ROE of -0.62%. Regarding short-term risk, PIIIW is more volatile compared to FTRP. This indicates potentially higher risk in terms of short-term price fluctuations for PIIIW.Check FTRP's competition here
PIIIW vs GBNH Comparison July 2025
PIIIW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 33K. In comparison, GBNH has a market cap of 5.5M. Regarding current trading prices, PIIIW is priced at $0.01, while GBNH trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of -0.01, whereas GBNH's P/E ratio is -0.06. In terms of profitability, PIIIW's ROE is -1.29%, compared to GBNH's ROE of +15.74%. Regarding short-term risk, PIIIW is less volatile compared to GBNH. This indicates potentially lower risk in terms of short-term price fluctuations for PIIIW.Check GBNH's competition here
PIIIW vs RHE Comparison July 2025
PIIIW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 33K. In comparison, RHE has a market cap of 5.2M. Regarding current trading prices, PIIIW is priced at $0.01, while RHE trades at $2.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of -0.01, whereas RHE's P/E ratio is -1.79. In terms of profitability, PIIIW's ROE is -1.29%, compared to RHE's ROE of +1.52%. Regarding short-term risk, PIIIW is more volatile compared to RHE. This indicates potentially higher risk in terms of short-term price fluctuations for PIIIW.Check RHE's competition here
PIIIW vs MNDR Comparison July 2025
PIIIW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 33K. In comparison, MNDR has a market cap of 4.6M. Regarding current trading prices, PIIIW is priced at $0.01, while MNDR trades at $1.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of -0.01, whereas MNDR's P/E ratio is -0.15. In terms of profitability, PIIIW's ROE is -1.29%, compared to MNDR's ROE of -5.70%. Regarding short-term risk, PIIIW is more volatile compared to MNDR. This indicates potentially higher risk in terms of short-term price fluctuations for PIIIW.Check MNDR's competition here
PIIIW vs ATIP Comparison July 2025
PIIIW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 33K. In comparison, ATIP has a market cap of 3M. Regarding current trading prices, PIIIW is priced at $0.01, while ATIP trades at $0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of -0.01, whereas ATIP's P/E ratio is -0.03. In terms of profitability, PIIIW's ROE is -1.29%, compared to ATIP's ROE of +1.77%. Regarding short-term risk, PIIIW is more volatile compared to ATIP. This indicates potentially higher risk in terms of short-term price fluctuations for PIIIW.Check ATIP's competition here
PIIIW vs NIVFW Comparison July 2025
PIIIW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 33K. In comparison, NIVFW has a market cap of 2.4M. Regarding current trading prices, PIIIW is priced at $0.01, while NIVFW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of -0.01, whereas NIVFW's P/E ratio is N/A. In terms of profitability, PIIIW's ROE is -1.29%, compared to NIVFW's ROE of -0.39%. Regarding short-term risk, PIIIW is more volatile compared to NIVFW. This indicates potentially higher risk in terms of short-term price fluctuations for PIIIW.Check NIVFW's competition here
PIIIW vs IONM Comparison July 2025
PIIIW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 33K. In comparison, IONM has a market cap of 2M. Regarding current trading prices, PIIIW is priced at $0.01, while IONM trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of -0.01, whereas IONM's P/E ratio is N/A. In terms of profitability, PIIIW's ROE is -1.29%, compared to IONM's ROE of +0.75%. Regarding short-term risk, PIIIW is less volatile compared to IONM. This indicates potentially lower risk in terms of short-term price fluctuations for PIIIW.Check IONM's competition here
PIIIW vs IMACW Comparison July 2025
PIIIW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 33K. In comparison, IMACW has a market cap of 1.7M. Regarding current trading prices, PIIIW is priced at $0.01, while IMACW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of -0.01, whereas IMACW's P/E ratio is N/A. In terms of profitability, PIIIW's ROE is -1.29%, compared to IMACW's ROE of +2.05%. Regarding short-term risk, PIIIW is less volatile compared to IMACW. This indicates potentially lower risk in terms of short-term price fluctuations for PIIIW.Check IMACW's competition here
PIIIW vs SYRA Comparison July 2025
PIIIW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 33K. In comparison, SYRA has a market cap of 1.2M. Regarding current trading prices, PIIIW is priced at $0.01, while SYRA trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of -0.01, whereas SYRA's P/E ratio is -0.31. In terms of profitability, PIIIW's ROE is -1.29%, compared to SYRA's ROE of -1.04%. Regarding short-term risk, PIIIW is more volatile compared to SYRA. This indicates potentially higher risk in terms of short-term price fluctuations for PIIIW.Check SYRA's competition here
PIIIW vs CCM Comparison July 2025
PIIIW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 33K. In comparison, CCM has a market cap of 885.3K. Regarding current trading prices, PIIIW is priced at $0.01, while CCM trades at $5.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of -0.01, whereas CCM's P/E ratio is -0.55. In terms of profitability, PIIIW's ROE is -1.29%, compared to CCM's ROE of +0.08%. Regarding short-term risk, PIIIW is more volatile compared to CCM. This indicates potentially higher risk in terms of short-term price fluctuations for PIIIW.Check CCM's competition here
PIIIW vs RHE-PA Comparison July 2025
PIIIW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 33K. In comparison, RHE-PA has a market cap of 674.5K. Regarding current trading prices, PIIIW is priced at $0.01, while RHE-PA trades at $0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of -0.01, whereas RHE-PA's P/E ratio is -0.09. In terms of profitability, PIIIW's ROE is -1.29%, compared to RHE-PA's ROE of +1.52%. Regarding short-term risk, PIIIW is less volatile compared to RHE-PA. This indicates potentially lower risk in terms of short-term price fluctuations for PIIIW.Check RHE-PA's competition here
PIIIW vs BACK Comparison July 2025
PIIIW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 33K. In comparison, BACK has a market cap of 227.1K. Regarding current trading prices, PIIIW is priced at $0.01, while BACK trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of -0.01, whereas BACK's P/E ratio is -0.01. In terms of profitability, PIIIW's ROE is -1.29%, compared to BACK's ROE of +2.05%. Regarding short-term risk, PIIIW is more volatile compared to BACK. This indicates potentially higher risk in terms of short-term price fluctuations for PIIIW.Check BACK's competition here
PIIIW vs NVOS Comparison July 2025
PIIIW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 33K. In comparison, NVOS has a market cap of 65.1K. Regarding current trading prices, PIIIW is priced at $0.01, while NVOS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of -0.01, whereas NVOS's P/E ratio is N/A. In terms of profitability, PIIIW's ROE is -1.29%, compared to NVOS's ROE of -1.20%. Regarding short-term risk, PIIIW is less volatile compared to NVOS. This indicates potentially lower risk in terms of short-term price fluctuations for PIIIW.Check NVOS's competition here
PIIIW vs TVTY Comparison July 2025
PIIIW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 33K. In comparison, TVTY has a market cap of 0. Regarding current trading prices, PIIIW is priced at $0.01, while TVTY trades at $32.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of -0.01, whereas TVTY's P/E ratio is 19.06. In terms of profitability, PIIIW's ROE is -1.29%, compared to TVTY's ROE of +1.75%. Regarding short-term risk, PIIIW is more volatile compared to TVTY. This indicates potentially higher risk in terms of short-term price fluctuations for PIIIW.Check TVTY's competition here
PIIIW vs TLMDW Comparison July 2025
PIIIW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 33K. In comparison, TLMDW has a market cap of 0. Regarding current trading prices, PIIIW is priced at $0.01, while TLMDW trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of -0.01, whereas TLMDW's P/E ratio is N/A. In terms of profitability, PIIIW's ROE is -1.29%, compared to TLMDW's ROE of -0.46%. Regarding short-term risk, PIIIW is more volatile compared to TLMDW. This indicates potentially higher risk in terms of short-term price fluctuations for PIIIW.Check TLMDW's competition here
PIIIW vs DCGOW Comparison July 2025
PIIIW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 33K. In comparison, DCGOW has a market cap of 0. Regarding current trading prices, PIIIW is priced at $0.01, while DCGOW trades at $1.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of -0.01, whereas DCGOW's P/E ratio is N/A. In terms of profitability, PIIIW's ROE is -1.29%, compared to DCGOW's ROE of -0.00%. Regarding short-term risk, PIIIW is more volatile compared to DCGOW. This indicates potentially higher risk in terms of short-term price fluctuations for PIIIW.Check DCGOW's competition here
PIIIW vs NFH Comparison July 2025
PIIIW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 33K. In comparison, NFH has a market cap of 0. Regarding current trading prices, PIIIW is priced at $0.01, while NFH trades at $11.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of -0.01, whereas NFH's P/E ratio is -19.75. In terms of profitability, PIIIW's ROE is -1.29%, compared to NFH's ROE of -0.06%. Regarding short-term risk, PIIIW is more volatile compared to NFH. This indicates potentially higher risk in terms of short-term price fluctuations for PIIIW.Check NFH's competition here
PIIIW vs SLHGP Comparison July 2025
PIIIW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 33K. In comparison, SLHGP has a market cap of 0. Regarding current trading prices, PIIIW is priced at $0.01, while SLHGP trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of -0.01, whereas SLHGP's P/E ratio is -30.38. In terms of profitability, PIIIW's ROE is -1.29%, compared to SLHGP's ROE of -0.71%. Regarding short-term risk, PIIIW is more volatile compared to SLHGP. This indicates potentially higher risk in terms of short-term price fluctuations for PIIIW.Check SLHGP's competition here
PIIIW vs HNGR Comparison July 2025
PIIIW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 33K. In comparison, HNGR has a market cap of 0. Regarding current trading prices, PIIIW is priced at $0.01, while HNGR trades at $18.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of -0.01, whereas HNGR's P/E ratio is 19.71. In terms of profitability, PIIIW's ROE is -1.29%, compared to HNGR's ROE of +0.52%. Regarding short-term risk, PIIIW is more volatile compared to HNGR. This indicates potentially higher risk in terms of short-term price fluctuations for PIIIW.Check HNGR's competition here
PIIIW vs SLHG Comparison July 2025
PIIIW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 33K. In comparison, SLHG has a market cap of 0. Regarding current trading prices, PIIIW is priced at $0.01, while SLHG trades at $0.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of -0.01, whereas SLHG's P/E ratio is -1.48. In terms of profitability, PIIIW's ROE is -1.29%, compared to SLHG's ROE of N/A. Regarding short-term risk, PIIIW is more volatile compared to SLHG. This indicates potentially higher risk in terms of short-term price fluctuations for PIIIW.Check SLHG's competition here
PIIIW vs TLMD Comparison July 2025
PIIIW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 33K. In comparison, TLMD has a market cap of 0. Regarding current trading prices, PIIIW is priced at $0.01, while TLMD trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of -0.01, whereas TLMD's P/E ratio is -1.60. In terms of profitability, PIIIW's ROE is -1.29%, compared to TLMD's ROE of -0.46%. Regarding short-term risk, PIIIW is more volatile compared to TLMD. This indicates potentially higher risk in terms of short-term price fluctuations for PIIIW.Check TLMD's competition here
PIIIW vs DVCR Comparison July 2025
PIIIW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PIIIW stands at 33K. In comparison, DVCR has a market cap of 0. Regarding current trading prices, PIIIW is priced at $0.01, while DVCR trades at $10.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PIIIW currently has a P/E ratio of -0.01, whereas DVCR's P/E ratio is 28.34. In terms of profitability, PIIIW's ROE is -1.29%, compared to DVCR's ROE of -0.15%. Regarding short-term risk, PIIIW is more volatile compared to DVCR. This indicates potentially higher risk in terms of short-term price fluctuations for PIIIW.Check DVCR's competition here